drugset / Trial / NCT00744445

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445

Phase 2 Completed 46 enrolled Sunnybrook Health Sciences Centre
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this research study was to determine if the activity of erythropoietin (r-HuEPO) is time dependent when given to chronic renal failure patients at three different times of day.

Timeline

Start
1993-10
Primary completion
1998-08
Completion
1998-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic 50 iu/kg Subcutaneous